Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Apr;117(8):1803–1808. doi: 10.1111/j.1476-5381.1996.tb15358.x

Investigation of the involvement of the N-methyl-D-aspartate receptor macrocomplex in the development of spermine-induced CNS excitation in vivo.

K M Doyle 1, G G Shaw 1
PMCID: PMC1909563  PMID: 8732295

Abstract

1. The involvement of the N-methyl-D-aspartate (NMDA) receptor macrocomplex in the development of spermine-induced CNS excitation in vivo was investigated. 2. Injection of 100 micrograms of spermine into the left lateral cerebral ventricle of female Laca mice (20-25 g) resulted in the development of two distinct phases of CNS excitatory effects which were quantified by a scoring system. 3. The first phase effects occurred within minutes of injection and generally lasted for about 1 h. Most mice showed scratching of the upper body, frequent face washing and some mice developed clonic convulsions. By about 2 h after injection, the second phase of effects began to develop in the form of body tremor which worsened with time and culminated in fatal tonic convulsions, generally within 8 h of injection. 4. Pretreatment of the mice with dizocilpine (0.3 mg kg-1, i.p.) resulted in antagonism of the first phase of spermine-induced effects, but a higher dose (0.3 mg kg-1, (x2), i.p.) was necessary to inhibit the second phase effects. 5. Whereas the glutamate antagonist, 3-((R)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid (D-CPP) (10, 20 mg kg-1, i.p.), the glycine antagonist 7-chlorokynurenate (10, 30, 50 nmol, i.c.v.), or the polyamine antagonist ifenprodil (30, 60 mg kg-1, i.p.) antagonized the first phase of effects produced by spermine, these agents given as monotherapy, were ineffective against the development of the second phase of effects. 6. Co-administration of ifenprodil with either D-CPP or 7-chlorokynurenate resulted in a dose-dependent antagonism of the development of the second phase of spermine-induced effects. 7. It is concluded that the development of the two temporally distinct phases of spermine-induced effects may be mediated by pharmacologically distinct mechanisms, although the results suggest that the NMDA receptor macrocomplex may be involved in both phases of effects. Furthermore, a moderate dose of D-CPP or 7-chlorokynurenate appears to enhance the inhibitory potential of ifenprodil in vivo.

Full text

PDF
1803

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akaike N., Himori N. Antagonism of various tonic convulsions in mice by dextrorphan and dizocilpine. Naunyn Schmiedebergs Arch Pharmacol. 1993 Jun;347(6):652–657. doi: 10.1007/BF00166949. [DOI] [PubMed] [Google Scholar]
  2. Anderson D. J., Crossland J., Shaw G. G. The actions of spermidine and spermine on the central nervous system. Neuropharmacology. 1975 Aug;14(8):571–577. doi: 10.1016/0028-3908(75)90123-9. [DOI] [PubMed] [Google Scholar]
  3. Benveniste M., Mayer M. L. Multiple effects of spermine on N-methyl-D-aspartic acid receptor responses of rat cultured hippocampal neurones. J Physiol. 1993 May;464:131–163. doi: 10.1113/jphysiol.1993.sp019627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brittain R. T. The intracerebral effects of noradrenaline and its modification by drugs in the mouse. J Pharm Pharmacol. 1966 Sep;18(9):621–623. doi: 10.1111/j.2042-7158.1966.tb07944.x. [DOI] [PubMed] [Google Scholar]
  5. Chapman A. G., Meldrum B. S. Excitatory amino acid antagonists and epilepsy. Biochem Soc Trans. 1993 Feb;21(1):106–110. doi: 10.1042/bst0210106. [DOI] [PubMed] [Google Scholar]
  6. De Sarro G., De Sarro A. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats. Eur J Pharmacol. 1992 May 14;215(2-3):221–229. doi: 10.1016/0014-2999(92)90031-x. [DOI] [PubMed] [Google Scholar]
  7. Fahey J. M., Pritchard G. A., Miller L. G. Polyamine neurotoxicity is antagonized by dizocilpine in cultured chick cortical neurons. Neurosci Lett. 1993 Oct 14;161(1):109–112. doi: 10.1016/0304-3940(93)90152-b. [DOI] [PubMed] [Google Scholar]
  8. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K., Meguro H., Masaki H., Kumanishi T., Arakawa M. Molecular diversity of the NMDA receptor channel. Nature. 1992 Jul 2;358(6381):36–41. doi: 10.1038/358036a0. [DOI] [PubMed] [Google Scholar]
  9. Lynch D. R., Lawrence J. J., Lenz S., Anegawa N. J., Dichter M., Pritchett D. B. Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: differences with receptors formed from NR 1a and 2A. J Neurochem. 1995 Apr;64(4):1462–1468. doi: 10.1046/j.1471-4159.1995.64041462.x. [DOI] [PubMed] [Google Scholar]
  10. Nankai M., Fage D., Carter C. NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release. J Neurochem. 1995 May;64(5):2043–2048. doi: 10.1046/j.1471-4159.1995.64052043.x. [DOI] [PubMed] [Google Scholar]
  11. Nussenzveig I. Z., Sircar R., Wong M. L., Frusciante M. J., Javitt D. C., Zukin S. R. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists. Brain Res. 1991 Oct 11;561(2):285–291. doi: 10.1016/0006-8993(91)91606-2. [DOI] [PubMed] [Google Scholar]
  12. Palmer G. C., Harris E. W., Ray R., Stagnitto M. L., Schmiesing R. J. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Arch Int Pharmacodyn Ther. 1992 May-Jun;317:16–34. [PubMed] [Google Scholar]
  13. Ransom R. W., Stec N. L. Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J Neurochem. 1988 Sep;51(3):830–836. doi: 10.1111/j.1471-4159.1988.tb01818.x. [DOI] [PubMed] [Google Scholar]
  14. Reynolds I. J., Palmer A. M. Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors. J Neurochem. 1991 May;56(5):1731–1740. doi: 10.1111/j.1471-4159.1991.tb02074.x. [DOI] [PubMed] [Google Scholar]
  15. Rogawski M. A. The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs. 1992 Sep;44(3):279–292. doi: 10.2165/00003495-199244030-00001. [DOI] [PubMed] [Google Scholar]
  16. Sacaan A. I., Johnson K. M. Spermine enhances binding to the glycine site associated with the N-methyl-D-aspartate receptor complex. Mol Pharmacol. 1989 Dec;36(6):836–839. [PubMed] [Google Scholar]
  17. Subramaniam S., McGonigle P. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines. J Pharmacol Exp Ther. 1991 Feb;256(2):811–819. [PubMed] [Google Scholar]
  18. Turski L., Niemann W., Stephens D. N. Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids. Neuroscience. 1990;39(3):799–807. doi: 10.1016/0306-4522(90)90262-3. [DOI] [PubMed] [Google Scholar]
  19. Voltz C., Fage D., Carter C. Synergism between the NMDA receptor antagonistic effects of ifenprodil and the glycine antagonist, 7-chlorokynurenate, in vivo. Eur J Pharmacol. 1994 Apr 1;255(1-3):197–202. doi: 10.1016/0014-2999(94)90098-1. [DOI] [PubMed] [Google Scholar]
  20. Williams K., Pullan L. M., Romano C., Powel R. J., Salama A. I., Molinoff P. B. An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site. J Pharmacol Exp Ther. 1992 Aug;262(2):539–544. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES